No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
EGYPT – SEDICO Pharmaceutical has officially started operations at its new US$32 million (EGP 1 billion) oncology drugs factory in Giza, Egypt, to develop and produce cancer drugs. Located in…
Read More
ZIMBABWE – TM Pick n Pay has donated US$10 million to underprivileged children diagnosed with cancer and undergoing treatment in health facilities around Harare, Zimbabwe. The donation is under the…
Read More
AFRICA – FIND, a global alliance for diagnostics and KILELE Health Association have launched a community engagement coalition to expand cervical cancer screening in sub-Saharan Africa. The coalition will identify…
Read More
GERMANY — Bristol Myers Squibb, following its European approval last September, has announced that it will not be launching Opdualag, an infusion of Opdivo and new antibody relatlimab, in Germany…
Read More
UAE – A brand-new oncology facility christened the Fatima bint Mubarak Center has officially opened at the Cleveland Clinic Abu Dhabi in the United Arab Emirates (UAE) focused on personalized…
Read More
USA —Merck & Co Inc and AstraZeneca have announced that an independent committee of advisers to the U.S. Food and Drug Administration (FDA) will evaluate their application for the expanded…
Read More
KENYA – Self-collection sample test is seemingly becoming more preferred than pap smear for cervical cancer screening after most women in Kisii county chose it. An ongoing medical camp in…
Read More
KENYA – The Kenyatta University Teaching Research and Referral Hospital (KUTRRH) has installed CyberKnife’s stereotactic radiosurgery (SRS), and stereotactic body radiation therapy (SBRT) system, which enables clinicians to deliver precise,…
Read More
KENYA – The National Cancer Institute of Kenya (NCI Kenya) Regulation and Compliance Directorate has closed the cancer unit at Meru Teaching and Referral Hospital (MeTRH) over safety concerns. NCI…
Read More
GERMANY — Boehringer Ingelheim and 3T Biosciences have formed a strategic partnership and licensing agreement to develop next-generation cancer immunotherapies. Cancer immunotherapy uses the immune system to attack tumor cells…
Read More